A detailed history of Stifel Financial Corp transactions in Repligen Corp stock. As of the latest transaction made, Stifel Financial Corp holds 4,404 shares of RGEN stock, worth $712,831. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,404
Previous 4,178 5.41%
Holding current value
$712,831
Previous $526,000 24.52%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $27,072 - $37,821
226 Added 5.41%
4,404 $655,000
Q2 2024

Aug 13, 2024

SELL
$120.0 - $182.95 $151,440 - $230,882
-1,262 Reduced 23.2%
4,178 $526,000
Q1 2024

May 13, 2024

SELL
$170.78 - $208.42 $32,277 - $39,391
-189 Reduced 3.36%
5,440 $1 Million
Q4 2023

Feb 12, 2024

SELL
$114.17 - $185.35 $93,733 - $152,172
-821 Reduced 12.73%
5,629 $1.01 Million
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $31,780 - $40,420
-229 Reduced 3.43%
6,450 $1.03 Million
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $64,365 - $83,844
-465 Reduced 6.51%
6,679 $944,000
Q1 2023

May 12, 2023

SELL
$154.26 - $198.1 $2.46 Million - $3.15 Million
-15,920 Reduced 69.03%
7,144 $1.2 Million
Q4 2022

Feb 13, 2023

SELL
$162.42 - $220.56 $2.06 Million - $2.79 Million
-12,669 Reduced 35.45%
23,064 $3.9 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $167,478 - $267,483
-1,044 Reduced 2.84%
35,733 $6.69 Million
Q2 2022

Aug 15, 2022

BUY
$140.68 - $188.02 $1.64 Million - $2.19 Million
11,661 Added 46.43%
36,777 $5.97 Million
Q1 2022

May 13, 2022

BUY
$161.19 - $257.96 $90,266 - $144,457
560 Added 2.28%
25,116 $4.72 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $466,459 - $573,621
-1,884 Reduced 7.13%
24,556 $6.5 Million
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $2.95 Million - $4.91 Million
15,150 Added 134.19%
26,440 $7.64 Million
Q2 2021

Aug 13, 2021

SELL
$165.87 - $220.95 $75,304 - $100,311
-454 Reduced 3.87%
11,290 $2.25 Million
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $230,512 - $289,160
1,278 Added 12.21%
11,744 $2.28 Million
Q4 2020

Feb 12, 2021

BUY
$148.08 - $206.57 $527,312 - $735,595
3,561 Added 51.57%
10,466 $2.01 Million
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $122,142 - $157,795
997 Added 16.88%
6,905 $1.02 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $105,272 - $156,775
-1,116 Reduced 15.89%
5,908 $731,000
Q1 2020

May 14, 2020

BUY
$84.96 - $109.14 $82,836 - $106,411
975 Added 16.12%
7,024 $674,000
Q4 2019

Feb 13, 2020

BUY
$73.84 - $93.08 $100,865 - $127,147
1,366 Added 29.17%
6,049 $560,000
Q3 2019

Nov 13, 2019

SELL
$76.65 - $95.51 $476,303 - $593,499
-6,214 Reduced 57.02%
4,683 $360,000
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $302,327 - $479,429
5,578 Added 104.87%
10,897 $935,000
Q1 2019

May 14, 2019

BUY
$49.45 - $62.8 $263,024 - $334,033
5,319 New
5,319 $317,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.98B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.